ENHOPMA

What this means for you

Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79366725

Registration number

7404208

Mark type

Stylized text

Filed

06 Mar 2023

Published for opposition

12 Mar 2024

Registered

04 Jun 2024

Attorney of record

Max Vern

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain, of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases

Owner

• CELLTRION, INC., KR
• CELLTRION, INC., KR
• CELLTRION, INC., KR

Prosecution history

• 04 Apr 2025 — NEW REPRESENTATIVE AT IB RECEIVED
• 07 Dec 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 17 Nov 2024 — FINAL DISPOSITION NOTICE SENT TO IB
• 16 Nov 2024 — FINAL DISPOSITION PROCESSED
• 04 Sept 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
• 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 19 Mar 2024 — PUBLISHED FOR OPPOSITION
• 28 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 28 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 02 Feb 2024 — WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
• 31 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 24 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 23 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE